ArticleInternational journal of preventive medicine2025

Long-Term Adverse Events of Rituximab in Multiple Sclerosis Patients, Isfahan, Iran.

Ali Rahimisadegh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.